期刊文献+

依那西普抗体的活性结构保护 被引量:1

Bioactive Structural Protection of Antibody Etanercept
在线阅读 下载PDF
导出
摘要 采用Gromacs软件,利用分子动力学模拟方法,研究了在真空干燥及水溶液环境下,抗体蛋白药物依那西普在不同保护剂体系中分子结构的稳定性。通过分析依那西普的结构变化以及抗体蛋白与保护剂之间的相互作用,采用单因素方差法,给出了不同保护体系与抗体蛋白之间的差异。结果表明,海藻糖–甘露醇复合保护体系和蔗糖–甘露醇复合保护体系对抗体蛋白的稳定效果明显优于海藻糖单一保护体系,其中海藻糖–甘露醇复合保护体系对依那西普抗体蛋白活性结构的保护效果最好。这说明不同的小分子保护剂可以协同保护蛋白药物的活性结构,溶剂化环境对于抗体蛋白的稳定性具有显著影响,而真空冷冻干燥可以提高其结构的稳定性。 The structural stability of antibody protein etanercept was studied in different protective systems, including the vacuum freeze-drying and aqueous solution environment, by using the molecular dynamics simulation method with Gromacs software. Through analyzing the structural changes of etanercept as well as the intermolecular interaction between etanercept and protectants, the significant difference between various protective systems and antibody protein was analyzed by one-factor analysis of variance. The results show that the stabilizing effect of both trehalose-mannitol complex protective system and the sucrose-mannitol complex system on antibody protein is better than that of the single trehalose system, and the trehalose-mannitol complex protective system is most effective to preserve the bioactive structure of etanercept.This indicates that the small molecule protectants can synergistically protect the bioactive structure of antibody proteins, and the solvent environment has a significant effect on the stability of antibody proteins, while the vacuum freeze-drying can improve the stability of their bioactive structure.
作者 房筱 李代禧 郭柏松 杨春生 FANG Xiao;LI Daixi;GUO Baisong;YANG Chunsheng(School of Medical Instrument and Food Engineering,University of Shanghai for Science and Technology,Shanghai 200093,China;Injection Laboratory,Shanghai Tofflon Science and Technology Co.,Ltd.,Shanghai 201108,China)
出处 《上海理工大学学报》 CAS 北大核心 2018年第3期225-230,258,共7页 Journal of University of Shanghai For Science and Technology
基金 上海市自然科学基金资助项目(12ZR1420400) 上海市科委国际合作项目(12430702000) 上海市教委创新项目(14YZ092)
关键词 依那西普 生物活性结构 稳定性 协同保护 etanercept bioactive structure stability synergistical protection
  • 相关文献

参考文献16

二级参考文献237

  • 1胡大伟,鲍春德,陈顺乐,古洁若,栗占国,孙凌云,韩星海,倪立青.重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白治疗类风湿关节炎双盲随机多中心对照临床研究[J].中华风湿病学杂志,2005,9(11):664-668. 被引量:86
  • 2陈声明,吕琴.微生物冷冻干燥的抗性机理[J].微生物学通报,1996,23(4):236-238. 被引量:39
  • 3施安国.类风湿关节炎治疗药物研究进展[J].中国新药杂志,2006,15(2):92-95. 被引量:8
  • 4周满生.国际竞争视角下中、印、美的教育创新与人才培养[J].北京大学教育评论,2007,5(3):157-166. 被引量:13
  • 5涤平.海藻糖对细胞膜和蛋白质在干燥时的保护作用[J].工业微生物,1996,26(3):49-50.
  • 6CALIN A, GARRETT S, WHITELOCK H, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the bath ankylosing spondylitis functional index[ J]. J Rheumatol, 1994, 21(12) :2281 -2285.
  • 7DAVIS JC, VAN DER HEIJDE D, DOUGADOS M, et al. Reduction in health related quality of life in patients with ankylosing spondylitis and improvements with etanercept therapy [J]. Arthritis Rheum,2005,53(4) :494 -501.
  • 8BRAUN J,SIEPER J. The sacroiliac joint in the spondyloarthropathies [ J ]. Curr Opin Rheumatol, 1996,8 (4) : 275 - 297.
  • 9GRATACOS J ,COLLADO A , FILELLA X , et al. Serum cytokines (IL-6 ,TNF-α, IL-1 β and IFN-γ )in ankylosing spnndylilis:a close correlation between serum IL-6 and disease activity and severity[J] . Br JRheumatol,1994 ,33 (10):927-931.
  • 10ANDERSON JJ, BARON G, VAN DER HElJDE D, et al. Ankylosing spondylitis assessment group preliminary definition of shortterm improvement in ankylosing spondylitis [ J ]. Arthritis Rheum, 2001, 44(8) : 1876 - 1886.

共引文献151

同被引文献8

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部